Tax

Income Tax at U.S. Statutory Rate

Vertex Pharmaceuticals Income Tax at U.S. Statutory Rate remained flat by 0.0% to $243.78M in Q4 2025 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionTax
CategoryProfitability
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Used as a benchmark to evaluate the effectiveness of the company's tax planning and the impact of various tax incentives.

Detailed definition

The theoretical income tax expense calculated by applying the standard federal statutory tax rate to the company's pre-t...

Peer comparison

Standard baseline metric in tax rate reconciliations for all public companies.

Metric ID: is_cat_income_tax_at_statutory_rate

Historical Data

1 years
 FY'25
Value$975.10M

Income Tax at U.S. Statutory Rate at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's income tax at u.s. statutory rate?
Vertex Pharmaceuticals (VRTX) reported income tax at u.s. statutory rate of $243.78M in Q4 2025.
What does income tax at u.s. statutory rate mean?
The income tax expense calculated using the standard federal tax rate before any adjustments.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.